BeStock  
Stocks › Biotechnology › VKTX

Viking Therapeutics VKTX

US equityMarket cap rank #2398Biotechnology
$24.77 −$1.07 (-4.14%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.10 +1.33%
Open$25.62
Prev close$25.84
Day range$24.67 – $26.50
Volume3.65M
Market cap$3.16B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts16
Average target$93.53+277.6% vs. price
  • Buy 94%
  • Hold 6%
Low $34.00Now $24.77Avg $93.53High $125.00

Recent rating changes

The last 20 actions on file set price targets from $34.00 to $125.00, averaging $95.75.

DateFirmRatingTarget
30 Oct 2026 CCORF BUY $118.00
30 Oct 2026 Maxim Group BUY $70.00
29 Oct 2026 UBS BUY $94.00
29 Oct 2026 Piper Sandler BUY $90.00
29 Oct 2026 Maxim Group BUY $70.00
29 Oct 2026 BTIG BUY $125.00
29 Oct 2026 Morgan Stanley BUY $95.00
29 Oct 2026 Stifel BUY $95.00
29 Oct 2026 B. Riley Securities BUY $85.00
29 Oct 2026 H.C. Wainwright BUY $102.00
29 Oct 2026 Oppenheimer BUY $120.00
28 Oct 2026 Cantor Fitzgerald BUY $100.00
28 Oct 2026 Goldman Sachs HOLD $34.00
20 Oct 2026 CCORF BUY $106.00
15 Oct 2026 UBS BUY $94.00
14 Oct 2026 CCORF BUY $114.00
14 Oct 2026 H.C. Wainwright BUY $102.00
7 Oct 2026 CCORF BUY $114.00
7 Oct 2026 Truist Financial BUY $85.00
6 Oct 2026 H.C. Wainwright BUY $102.00

Discussion

No comments yet — be the first to weigh in on VKTX.

Sign in to join the discussion.

Scroll to Top